Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3170 of 6351
-
New hope for advanced cancer: experimental drug DR30206 enters human testing
Disease control Recruiting nowThis study is to characterize the safety,tolerability, pharmacokinetics(PK),and preliminary anti-tumor activity of DR30206, in subjects with advanced or metastatic solid tumors
Phase 1 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Timing of MS drug may change disease course
Disease control Recruiting nowThis non-interventional study will compare the effect of Ofatumumab treatment between patients that began Ofatumumab within the 3 years after Multiple Sclerosis diagnosis and patients that began Ofatumumab with more than 3 years of Multiple Sclerosis diagnosis in a real-world set…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New supplement trial aims to fight chemo fatigue in breast cancer patients
Symptom relief Recruiting nowThe goal of this clinical trial is to test the effect of the administration of APPORTAL® in addition to the SoC (recommended physical exercise), in patients with breast cancer, suffering from fatigue during neoadjuvant and adjuvant chemotherapy. The main questions it aims to answ…
Sponsor: Pharmanutra S.p.a. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New cancer drug combo enters first human tests
Disease control OngoingThis is a first-in-human Phase I, open-label, dose-escalation and expansion study designed to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, pharmacodynamic, and preliminary anti-tumor activity of RO7566802 as a single agent and in combination with atezolizu…
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Liver cancer patients: which drug works best after immunotherapy?
Knowledge-focused OngoingThis is an observational study in which only data will be collected from adults with unresectable hepatocellular carcinoma. These adults should be prescribed a different treatment after treatment with atezolizumab and bevacizumab, or another similar combination of drugs, by their…
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Diet and exercise program tested in men with advanced prostate cancer
Disease control Recruiting nowThe proposed pilot study aims at determining the feasibility of a lifestyle intervention including adherence to a personalised dietary regimen combined with regular physical activity in patients newly diagnosed with prostate cancer under androgen deprivation therapy.
Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New shot helps lower cholesterol when statins aren't enough
Disease control CompletedThis is a Multicenter, Randomized, Double-Blind, Placebo-Parallel-Controlled, Phase II Clinical Stud to assess the reduction of low-density lipoprotein cholesterol (LDL-C) by SHR-1918 in patients with Hyperlipidemic.
Phase 2 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study tests best way to position ARDS patients to avoid bedsores
Symptom relief CompletedAcute respiratory distress syndrome (ARDS) is a diffuse inflammation of the lungs that occurs in a variety of diseases. According to the Berlin definition, ARDS is characterized by diffuse lung damage in patients with predisposing factors. Understanding the physiology of ARDS has…
Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New Immune-Boosting drug GEN1042 tested in japanese cancer patients
Disease control OngoingThis study evaluating GEN1042 will include multiple parts. In this study, GEN1042 alone (phase 1a) or GEN1042 in combination with other anticancer drug(s) (phase 1b) will be evaluated in Japanese participants. The main purpose is to assess the safety and tolerability of GEN1042 m…
Phase 1 • Sponsor: Genmab • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
New study: could a 30-Minute procedure end heavy periods for good?
Symptom relief Recruiting nowHeavy menstrual bleeding (HMB) affects 30% of women worldwide. It negatively influences physical activity, work productivity, sexual life and overall quality of life. In 2018, the FIGO (International Federation of Gynaecology and Obstetrics) revised its definition of AUB (FIGO-A…
Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Home-Based health program shows promise for chronic illness
Symptom relief CompletedThe Pictou County Personal Empowerment Program is a comprehensive health promotion program aiming to improve the quality of life as well as both physical and mental health in Adults living with chronic medical conditions. The program includes daily email communications over 6 mon…
Sponsor: Nova Scotia Health Authority • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
New breast CT scan could rival MRI for cancer detection
Diagnosis CompletedComparison between two diagnostic modalities for breast cancer diagnosis. Two different imaging systems are compared to evaluate the performance of the two systems
Sponsor: AB-CT - Advanced Breast-CT GmbH • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Stitch showdown: small bites may beat large bites for emergency belly surgery
Disease control OngoingThe goal of this trial is to compare the effectiveness of small bite versus large bite abdominal incision closure in emergency settings. It will also evaluate the safety and outcomes of each technique. The main questions it aims to answer are: Does small bite closure reduce the …
Phase 2/3 • Sponsor: Dow University of Health Sciences • Aim: Disease control
Last updated Jun 26, 2026 14:23 UTC
-
Diabetes drug shows promise for weight loss in Large-Waisted adults
Disease control OngoingMetformin is a drug used to treat patients with diabetes. The aim of this study is to examine the effect of Metformin along with a low-calorie diet on obese and/or overweight adults with an increased waist measurement. In addition, the study also aims to look at the effect of the…
Phase 4 • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New shot aims to ease stubborn nerve pain
Symptom relief CompletedIn this clinical trial, participants with nerve pain after shingles or nerve injury will receive injections with NT 201 or placebo. The purpose is to measure the decrease of nerve pain with NT 201 compared to placebo. Trial details include: * Trial duration: 22-23 weeks; * Trea…
Phase 2 • Sponsor: Merz Therapeutics GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New flu drug under watch in kids: will it work and stop family spread?
Disease control Recruiting nowThis study consists of two parts: Part A Surveillance and Part B Transmission. The main purpose of Part A is to evaluate the prevalence of pre-dose and treatment-emergent amino acid substitutions in pediatric participants' \<12 years with influenza treated with baloxavir marboxi…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Glucose monitors may outshine standard test for pregnancy diabetes
Knowledge-focused OngoingGestational diabetes (GDM) develops during pregnancy and is becoming increasingly common. The condition is associated with adverse outcomes for mother and baby during both the pregnancy and delivery period. This study compares glucose variability (recorded by a continuous glucose…
Sponsor: Portsmouth Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New texting tool aims to save cyberbullied teens from suicide
Knowledge-focused Recruiting nowThe objective of this study is to test the feasibility and preliminary efficacy of Flourish (formerly referred to as imHere4U), a digital suicide prevention intervention for cyberbullied adolescents. The specific aims are to: Aim #1: Conduct a randomized controlled trial (RCT) …
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Vibrating neck device may help rare voice disorder
Symptom relief CompletedThe general aim of the study was to provide evidence for the usability and feasibility of applying vibro-tactile stimulation (VTS) at home as a non-invasive form of neuromodulation to improve speech in people with spasmodic dysphonia (laryngeal dystonia). This work addresses a cl…
Phase 1/2 • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Can nasal sprays replace antibiotics for sinus infections? major study aims to find out
Symptom relief Recruiting nowSinus infections (also called acute rhinosinusitis or ARS) affect about 15% of adults each year, and are one of the top reasons people receive antibiotics in outpatient settings. Since most sinus infections are caused by viruses, many patients who take antibiotics for this condit…
Phase 4 • Sponsor: Daniel Merenstein • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC